Clin2
NCT07300462Likely a fitEnrolling by invitation

Oral cholera vaccine safety study for children

Diarrhea

Part of Digestive system, Infections clinical trials.

This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
6,000 people
Ages
2 years to 14 years
Study type
Interventional

Who can take part

  • Child is 2 to 14 years old.
  • Has not been vaccinated against cholera before.
  • Has no fever (temperature below 37.0°C) on the day of vaccination.
  • Has not had diarrhea or used antibiotics in the last 7 days.
  • Has not received other vaccines recently (within 14 days for live vaccines, 7 days for others, or 12 months for rotavirus vaccine).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07205926Recruiting· Phase 1
Testing a new Shigella vaccine in healthy adults

This trial tests a new Shigella vaccine in healthy adults to see if it is safe and creates a good immune response. It is a first-in-human study, meaning this is the first time the vaccine is given to people.

Cincinnati, Ohio
NCT07509047Recruiting· Phase 2
Cholera vaccine safety study for adults and children

This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.

Nairobi, Kenyatta National Hospital Complex
NCT07107516Recruiting· Phase 1
Testing an oral cholera vaccine in healthy adults

This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.

Lusaka, Lusaka Province
NCT06455852Recruiting
How well does the cholera vaccine protect you?

This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.

Dhaka
NCT07304284Recruiting· Phase 3
Cholera vaccine study for healthy adults and people with HIV

This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.

Durban, Eastern Cape
NCT07270796Not yet recruiting· Phase 1
DuoChol oral cholera vaccine safety study

This study tests a new oral cholera vaccine called DuoChol to see if it is safe and helps your body build protection. It might be an option for healthy adults who want to help develop a better vaccine against cholera.

Stockholm

Hear when a new Diarrhea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.